197 related articles for article (PubMed ID: 26689008)
41. Amyotrophic lateral sclerosis, frontotemporal dementia and beyond: the TDP-43 diseases.
Geser F; Martinez-Lage M; Kwong LK; Lee VM; Trojanowski JQ
J Neurol; 2009 Aug; 256(8):1205-14. PubMed ID: 19271105
[TBL] [Abstract][Full Text] [Related]
42. ALS/FTLD-linked TDP-43 regulates neurite morphology and cell survival in differentiated neurons.
Han JH; Yu TH; Ryu HH; Jun MH; Ban BK; Jang DJ; Lee JA
Exp Cell Res; 2013 Aug; 319(13):1998-2005. PubMed ID: 23742895
[TBL] [Abstract][Full Text] [Related]
43. Stress granules in neurodegeneration--lessons learnt from TAR DNA binding protein of 43 kDa and fused in sarcoma.
Bentmann E; Haass C; Dormann D
FEBS J; 2013 Sep; 280(18):4348-70. PubMed ID: 23587065
[TBL] [Abstract][Full Text] [Related]
44. Pathogenic Mutation of TDP-43 Impairs RNA Processing in a Cell Type-Specific Manner: Implications for the Pathogenesis of ALS/FTLD.
Imaizumi K; Ideno H; Sato T; Morimoto S; Okano H
eNeuro; 2022; 9(3):. PubMed ID: 35641224
[TBL] [Abstract][Full Text] [Related]
45. Heterogeneous Nuclear Ribonucleoprotein E2 (hnRNP E2) Is a Component of TDP-43 Aggregates Specifically in the A and C Pathological Subtypes of Frontotemporal Lobar Degeneration.
Kattuah W; Rogelj B; King A; Shaw CE; Hortobágyi T; Troakes C
Front Neurosci; 2019; 13():551. PubMed ID: 31213972
[TBL] [Abstract][Full Text] [Related]
46. HDAC1 dysregulation induces aberrant cell cycle and DNA damage in progress of TDP-43 proteinopathies.
Wu CC; Jin LW; Wang IF; Wei WY; Ho PC; Liu YC; Tsai KJ
EMBO Mol Med; 2020 Jun; 12(6):e10622. PubMed ID: 32449313
[TBL] [Abstract][Full Text] [Related]
47. TDP-43 localizes in mRNA transcription and processing sites in mammalian neurons.
Casafont I; Bengoechea R; Tapia O; Berciano MT; Lafarga M
J Struct Biol; 2009 Sep; 167(3):235-41. PubMed ID: 19539030
[TBL] [Abstract][Full Text] [Related]
48. Drosophila TDP-43 dysfunction in glia and muscle cells cause cytological and behavioural phenotypes that characterize ALS and FTLD.
Diaper DC; Adachi Y; Lazarou L; Greenstein M; Simoes FA; Di Domenico A; Solomon DA; Lowe S; Alsubaie R; Cheng D; Buckley S; Humphrey DM; Shaw CE; Hirth F
Hum Mol Genet; 2013 Oct; 22(19):3883-93. PubMed ID: 23727833
[TBL] [Abstract][Full Text] [Related]
49. TDP-43-mediated neurodegeneration: towards a loss-of-function hypothesis?
Vanden Broeck L; Callaerts P; Dermaut B
Trends Mol Med; 2014 Feb; 20(2):66-71. PubMed ID: 24355761
[TBL] [Abstract][Full Text] [Related]
50. Epitope mapping of antibodies against TDP-43 and detection of protease-resistant fragments of pathological TDP-43 in amyotrophic lateral sclerosis and frontotemporal lobar degeneration.
Tsuji H; Nonaka T; Yamashita M; Masuda-Suzukake M; Kametani F; Akiyama H; Mann DM; Tamaoka A; Hasegawa M
Biochem Biophys Res Commun; 2012 Jan; 417(1):116-21. PubMed ID: 22133678
[TBL] [Abstract][Full Text] [Related]
51. Regulation of TDP-43 phosphorylation in aging and disease.
Eck RJ; Kraemer BC; Liachko NF
Geroscience; 2021 Aug; 43(4):1605-1614. PubMed ID: 34032984
[TBL] [Abstract][Full Text] [Related]
52. TDP-43 N terminus encodes a novel ubiquitin-like fold and its unfolded form in equilibrium that can be shifted by binding to ssDNA.
Qin H; Lim LZ; Wei Y; Song J
Proc Natl Acad Sci U S A; 2014 Dec; 111(52):18619-24. PubMed ID: 25503365
[TBL] [Abstract][Full Text] [Related]
53. Inside out: the role of nucleocytoplasmic transport in ALS and FTLD.
Boeynaems S; Bogaert E; Van Damme P; Van Den Bosch L
Acta Neuropathol; 2016 Aug; 132(2):159-173. PubMed ID: 27271576
[TBL] [Abstract][Full Text] [Related]
54. Does a loss of TDP-43 function cause neurodegeneration?
Xu ZS
Mol Neurodegener; 2012 Jun; 7():27. PubMed ID: 22697423
[TBL] [Abstract][Full Text] [Related]
55. Cognitive decline typical of frontotemporal lobar degeneration in transgenic mice expressing the 25-kDa C-terminal fragment of TDP-43.
Caccamo A; Majumder S; Oddo S
Am J Pathol; 2012 Jan; 180(1):293-302. PubMed ID: 22067910
[TBL] [Abstract][Full Text] [Related]
56. Loss of TDP-43 oligomerization or RNA binding elicits distinct aggregation patterns.
Pérez-Berlanga M; Wiersma VI; Zbinden A; De Vos L; Wagner U; Foglieni C; Mallona I; Betz KM; Cléry A; Weber J; Guo Z; Rigort R; de Rossi P; Manglunia R; Tantardini E; Sahadevan S; Stach O; Hruska-Plochan M; Allain FH; Paganetti P; Polymenidou M
EMBO J; 2023 Sep; 42(17):e111719. PubMed ID: 37431963
[TBL] [Abstract][Full Text] [Related]
57. An acetylation switch controls TDP-43 function and aggregation propensity.
Cohen TJ; Hwang AW; Restrepo CR; Yuan CX; Trojanowski JQ; Lee VM
Nat Commun; 2015 Jan; 6():5845. PubMed ID: 25556531
[TBL] [Abstract][Full Text] [Related]
58. Metabolism and mis-metabolism of the neuropathological signature protein TDP-43.
Huang CC; Bose JK; Majumder P; Lee KH; Huang JT; Huang JK; Shen CK
J Cell Sci; 2014 Jul; 127(Pt 14):3024-38. PubMed ID: 24860144
[TBL] [Abstract][Full Text] [Related]
59. Distinct pathways leading to TDP-43-induced cellular dysfunctions.
Yamashita M; Nonaka T; Hirai S; Miwa A; Okado H; Arai T; Hosokawa M; Akiyama H; Hasegawa M
Hum Mol Genet; 2014 Aug; 23(16):4345-56. PubMed ID: 24698978
[TBL] [Abstract][Full Text] [Related]
60. Neurodegeneration of brain networks in the amyotrophic lateral sclerosis-frontotemporal lobar degeneration (ALS-FTLD) continuum: evidence from MRI and MEG studies.
Trojsi F; Sorrentino P; Sorrentino G; Tedeschi G
CNS Spectr; 2018 Dec; 23(6):378-387. PubMed ID: 29076800
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
